298 related articles for article (PubMed ID: 36043746)
1. Heterocycles in Breast Cancer Treatment: The Use of Pyrazole Derivatives.
Ardevines S; Marqués-López E; Herrera RP
Curr Med Chem; 2023; 30(10):1145-1174. PubMed ID: 36043746
[TBL] [Abstract][Full Text] [Related]
2. Overview of recent developments of pyrazole derivatives as an anticancer agent in different cell line.
Bennani FE; Doudach L; Cherrah Y; Ramli Y; Karrouchi K; Ansar M; Faouzi MEA
Bioorg Chem; 2020 Apr; 97():103470. PubMed ID: 32120072
[TBL] [Abstract][Full Text] [Related]
3. Recently reported biological activities of pyrazole compounds.
Faria JV; Vegi PF; Miguita AGC; Dos Santos MS; Boechat N; Bernardino AMR
Bioorg Med Chem; 2017 Nov; 25(21):5891-5903. PubMed ID: 28988624
[TBL] [Abstract][Full Text] [Related]
4. Current scenario of pyrazole hybrids with in vivo therapeutic potential against cancers.
Xu Z; Zhuang Y; Chen Q
Eur J Med Chem; 2023 Sep; 257():115495. PubMed ID: 37209450
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis, and Biological Evaluation of Novel Thiazolyl Substituted Bis-pyrazole Oxime Derivatives with Potent Antitumor Activities by Selectively Inducing Apoptosis and ROS in Cancer Cells.
Xiong B; Chen S; Zhu P; Huang M; Gao W; Zhu R; Qian J; Peng Y; Zhang Y; Dai H; Ling Y
Med Chem; 2019; 15(7):743-754. PubMed ID: 30147012
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of Chromone-Related Pyrazole Compounds.
Santos CMM; Silva VLM; Silva AMS
Molecules; 2017 Oct; 22(10):. PubMed ID: 28981465
[TBL] [Abstract][Full Text] [Related]
7. Recent advanced in bioactive systems containing pyrazole fused with a five membered heterocycle.
Raffa D; Maggio B; Raimondi MV; Cascioferro S; Plescia F; Cancemi G; Daidone G
Eur J Med Chem; 2015 Jun; 97():732-46. PubMed ID: 25549911
[TBL] [Abstract][Full Text] [Related]
8. Recent Advancement of Pyrazole Scaffold Based Neuroprotective Agents: A Review.
Das S; Akbar S; Ahmed B; Dewangan RP; Iqubal MK; Iqubal A; Chawla P; Pottoo FH; Joseph A
CNS Neurol Disord Drug Targets; 2022; 21(10):940-951. PubMed ID: 34080970
[TBL] [Abstract][Full Text] [Related]
9. Recent Advances in the Development of Pyrazole Derivatives as Anticancer Agents.
Zhang Y; Wu C; Zhang N; Fan R; Ye Y; Xu J
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628906
[TBL] [Abstract][Full Text] [Related]
10. A novel series of pyrazole-platinum(II) complexes as potential anti-cancer agents that induce cell cycle arrest and apoptosis in breast cancer cells.
Czarnomysy R; Surażyński A; Muszynska A; Gornowicz A; Bielawska A; Bielawski K
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1006-1023. PubMed ID: 29862867
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and structure-activity relationship study of novel pyrazole-based heterocycles as potential antitumor agents.
Farag AM; Ali KA; El-Debss TM; Mayhoub AS; Amr AG; Abdel-Hafez NA; Abdulla MM
Eur J Med Chem; 2010 Dec; 45(12):5887-98. PubMed ID: 20950898
[TBL] [Abstract][Full Text] [Related]
12. Pyrazole derivatives as antitumor, anti-inflammatory and antibacterial agents.
Liu JJ; Zhao MY; Zhang X; Zhao X; Zhu HL
Mini Rev Med Chem; 2013 Nov; 13(13):1957-66. PubMed ID: 23937232
[TBL] [Abstract][Full Text] [Related]
13. Current progress on antioxidants incorporating the pyrazole core.
Silva VLM; Elguero J; Silva AMS
Eur J Med Chem; 2018 Aug; 156():394-429. PubMed ID: 30015075
[TBL] [Abstract][Full Text] [Related]
14. Discovery of Anticancer Agents from 2-Pyrazoline-Based Compounds.
Li QS; Shen BN; Zhang Z; Luo S; Ruan BF
Curr Med Chem; 2021; 28(5):940-962. PubMed ID: 32141413
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Substituted Pyrazole-Based Kinase Inhibitors in One Decade (2011-2020): Current Status and Future Prospects.
El-Gamal MI; Zaraei SO; Madkour MM; Anbar HS
Molecules; 2022 Jan; 27(1):. PubMed ID: 35011562
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of pyrazole/isoxazole linked arylcinnamides as tubulin polymerization inhibitors and potential antiproliferative agents.
Kamal A; Shaik AB; Rao BB; Khan I; Bharath Kumar G; Jain N
Org Biomol Chem; 2015 Oct; 13(40):10162-78. PubMed ID: 26303171
[TBL] [Abstract][Full Text] [Related]
17. The therapeutic voyage of pyrazole and its analogs: A review.
Khan MF; Alam MM; Verma G; Akhtar W; Akhter M; Shaquiquzzaman M
Eur J Med Chem; 2016 Sep; 120():170-201. PubMed ID: 27191614
[TBL] [Abstract][Full Text] [Related]
18. A Molecular Insight into Pyrazole Congeners as Antimicrobial, Anticancer, and Antimalarial Agents.
Karati D; Mahadik KR; Trivedi P; Kumar D
Med Chem; 2022; 18(10):1044-1059. PubMed ID: 35240964
[TBL] [Abstract][Full Text] [Related]
19. Pyrazole-containing pharmaceuticals: target, pharmacological activity, and their SAR studies.
Li G; Cheng Y; Han C; Song C; Huang N; Du Y
RSC Med Chem; 2022 Nov; 13(11):1300-1321. PubMed ID: 36439976
[TBL] [Abstract][Full Text] [Related]
20. Heterocyclization of 2-(2-phenylhydrazono)cyclohexane-1,3-dione to Synthesis Thiophene, Pyrazole and 1,2,4-triazine Derivatives with Anti-Tumor and Tyrosine Kinase Inhibitions.
Mohareb RM; Alwan ES
Anticancer Agents Med Chem; 2020; 20(10):1209-1220. PubMed ID: 32156245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
